Industry Intelligence for Technology, Industrial, and Emerging Sectors
Independent market intelligence and strategic analysis helping organizations understand technology adoption, industry trends, and competitive dynamics.
Trusted by Global Industry Leaders
Strategic Intelligence
In-depth market intelligence across global technology, industrial, and emerging sectors supporting strategic decision making.
Automation & Robotics
AI-enabled robotics, predictive maintenance and intelligent automation reshaping manufacturing operations.
Explore Research →Semiconductors
Advanced packaging, AI workloads and global fabrication investments reshaping semiconductor markets.
Explore Research →Energy & Power
Renewable integration, hydrogen investment and grid modernization accelerating energy transformation.
Explore Research →Agriculture Technology
Precision farming, automation and agrivoltaics expanding across global agricultural systems.
Explore Research →Healthcare Technologies
AI diagnostics, biotechnology and digital health platforms redefining healthcare delivery.
Explore Research →Advanced Materials
Next-generation materials enabling innovation across electronics, batteries and industrial manufacturing.
Explore Research →Featured Market Research
Predictive Maintenance Robotics Market
AI-enabled inspection and maintenance robots are expanding across industrial facilities as manufacturers prioritize predictive maintenance and operational uptime.
5G NTN Backhaul Market
Satellite backhaul is emerging as a key component of 5G Non-Terrestrial Networks, enabling coverage expansion for rural connectivity, maritime communications, and aviation networks.
Artificial Intelligence (AI) In Oil And Gas Market
AI-driven analytics and automation are enabling oil and gas companies to optimize drilling operations, enhance reservoir management, and improve predictive maintenance across upstream and downstream assets.
Thought Leadership
Insights and analysis from our research team on emerging technologies, market developments, and competitive dynamics.
Press Releases
Official announcements and market research updates from Knowledge Sourcing Intelligence (KSI).
Bioengineered Proteins and Enzymes Market is expected to reach USD 11.5 billion by 2031
The rise in the demand for biological products like biologics, industrial enzymes, and sustainable bioprocessing solutions from the pharmaceutical, food & beverage, agriculture, and biotechnology industries are fueling the growth of these enzymes and proteins as bioengineered products. Proteins and enzymes with high efficiency and specific applications are being developed with ever increasing efficiency, thanks to the recombinant DNA technology, synthetic biology and protein engineering. Moreover, the growing investments for biopharmaceutical production, diversified application area in diagnostics and therapeutics, and the growing use of enzyme-based processes in the industrial sector are further pushing the market forward.
Biopharmaceutical Contract Development and Manufacturing (CDMO) Market is expected to reach USD 32.7 billion by 2031
The biopharmaceutical contract development and manufacturing (CDMO) market is seeing a surging uptake in outsourcing by pharmaceutical and biotechnology companies, the growing number of biopharmaceuticals being developed, and a demand for scalable and cost-efficient manufacturing solutions. The CDMOs offer clients integrated services in drug development, clinical and commercial manufacturing, and packaging, helping them to get to market faster and ensure regulatory compliance. As biologic, biosimilar and advanced therapies become more complex, the need for specialty CDMO partners is increasing at an even more rapid pace.
Synthetic Biology Healthcare Applications Market is expected to reach USD 21.9 billion by 2031
The healthcare applications of synthetic biology are rapidly evolving from exploratory research to regulated therapeutic commercialisation, through 2025-2026 government-backed initiatives in biologics, artificial intelligence (AI)-assisted molecular engineering and programmable cellular therapeutics. In 2025, the U.S. Food and Drug Administration (FDA) received 46 Novel Drug Applications (NDAs) reporting novel biologics and/or advanced therapy, indicating that the regulatory framework for engineered biological platforms is becoming more accepting and systematic over time. In addition, OECD's "2025 Technology Assessment" identified AI and robotics integrated with synthetic biology as one of the most significant drivers of disruptive innovation in healthcare, primarily within the areas of protein engineering, genomic medicine, and automated therapeutic discovery. While these AI-supported research programs are being developed, it should be noted that National Institutes of Health (NIH)-sponsored research is also developing the custom-protein design capabilities for precision therapeutics, immunotherapy optimisation, and next-generation biologics development.
The KSI Research Advantage
Knowledge Sourcing Intelligence delivers independent market intelligence across technology, industrial, and emerging sectors. Our research combines primary interviews, proprietary datasets, and structured forecasting models to help organizations make informed strategic decisions.
Research Coverage
8,000+ market research reports covering global industries including semiconductors, energy, automation, healthcare, agriculture, and advanced materials.
Industry Expertise
Research led by analysts specializing in sector-specific intelligence, technology adoption trends, competitive benchmarking, and investment analysis.
Strategic Forecasting
Multi-year market forecasts supported by quantitative modeling, regulatory analysis, and global industry tracking across more than 60 countries.
Need Custom Market Intelligence?
Speak with our analysts about custom research, market sizing, or competitive analysis.